Changes of Visual Vield and VEP in Patients of Radiation-induced Optic Neuropathy Treated with Ligustrazine Combined with Xingnaojing Injection

CHENG Xian-hua1; LI Zhi-ying2; JI Jian-ping2

doi:10.13422/j.cnki.syfjx.2013.05.020

您当前的位置：

首页 >

文章列表页 >

Changes of Visual Vield and VEP in Patients of Radiation-induced Optic Neuropathy Treated with Ligustrazine Combined with Xingnaojing Injection

更新时间：2024-09-23

- Changes of Visual Vield and VEP in Patients of Radiation-induced Optic Neuropathy Treated with Ligustrazine Combined with Xingnaojing Injection
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 5, Pages: 296-299(2013)
- 作者机构：
  
  1. 广州中医药大学
  2. 广州中医药大学第一附属医院眼科
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2013.05.020
  CLC： R276.7
- Published：2013
- 稿件说明：
移动端阅览
[1]程先华,李志英,冀建平.川芎嗪联合醒脑静对放射性视神经病变视野及视觉诱发电位的影响[J].中国实验方剂学杂志,2013,19(05):296-299.

CHENG Xian-hua1, LI Zhi-ying2, JI Jian-ping2. Changes of Visual Vield and VEP in Patients of Radiation-induced Optic Neuropathy Treated with Ligustrazine Combined with Xingnaojing Injection[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 296-299.
[1]程先华,李志英,冀建平.川芎嗪联合醒脑静对放射性视神经病变视野及视觉诱发电位的影响[J].中国实验方剂学杂志,2013,19(05):296-299. DOI： 10.13422/j.cnki.syfjx.2013.05.020.

CHENG Xian-hua1, LI Zhi-ying2, JI Jian-ping2. Changes of Visual Vield and VEP in Patients of Radiation-induced Optic Neuropathy Treated with Ligustrazine Combined with Xingnaojing Injection[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 296-299. DOI： 10.13422/j.cnki.syfjx.2013.05.020.

摘要

目的:研究分析川芎嗪联合醒脑静对放射性视神经病变（RION）患者的临床疗效。方法:回顾性分析2003年6月至2012年3月RION 18例（32只眼）

所有患者均给予川芎嗪注射液160 mg和醒脑静注射静脉20 mL静脉滴注

1次/d

2周1个疗程

2周后重复1个疗程

观察2周和6周的视力（VA）、视野平均光敏感度（MS）、视觉诱发电位（VEP）及视盘周围视网膜神经纤维层（RNFL）厚度。结果:视网膜光敏感度明显增加（P<0.01）、VEP P100波潜伏期明显缩短（P<0.01）、VEP P100波振幅明显提高（P<0.01）

视力和视盘周围视网膜神经纤维层厚度则没有明显改善。结论:川芎嗪联合醒脑静能很好的改善RION的视野和VEP。

Abstract

Objective:To assess the treatment methods of Ligustrazine combined with Xingnaojing injection to radiation-induced optic neuropathy（RION） patients.Method: A retrospective study

32 eyes in 18 patients with RION from June 2003 to March 2012.All patients were treated with Ligustrazine injection 160 mg and Xingnaojing Injection 20 mL each day for two weeks

and repeated it after two weeks interval.The visual acuity（VA）

visual field（VF）

visual evoked potential（VEP） and peripapillary retinal nerve fiber layer（RNFL） thickness were evaluated after 2nd

6th week.Result: After 2 and 6 weeks

there were in increasing mean sensitivity（P<0.01）

in shortening P100 latency（P<0.01）

in improving VEP amplitude（P<0.01） of the RION patients.But there weren’t statistical changes of in VA and RNFL.Conclusion: Ligustrazine combined with Xingnaojing injection can improve the mean sensitivity and VEP of RION.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Changes of Visual Vield and VEP in Patients of Radiation-induced Optic Neuropathy Treated with Ligustrazine Combined with Xingnaojing Injection

Investigation of Compatible Stability of Xingnaojing Injection Based on HPLC Fingerprint and Principal Component Analysis

Quality Analysis of Xinaojing Injection

Related Author

CHENG Xian-hua

LI Zhi-ying

JI Jian-ping

Ya-jing WANG

Meng-nan ZHOU

Jin-ling LI

Ya-nan WANG

Hui-shu SHI

Related Institution

Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine

Beijing District Institute of Drug Control

Dongcheng District Institute of Drug Control

Pharmacy College of Beijing Traditional Chinese Medicine University

Department of Neurosurgery,People’s Hospital of Liupanshui City

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰